Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Varroa destructor essential gene mRNA" broadly refers to messenger RNA transcripts from genes deemed essential for the survival, development, reproduction, and immunity of Varroa destructor, an ectoparasitic mite that infests honey bees and threatens apiculture worldwide by feeding on bee hemolymph and transmitting viruses. These mRNAs are differentially expressed across life stages such as egg, protonymph, deutonymph, and adult, with upregulation in pathways like ABC transporters, MAPK signaling, ubiquitin-proteasome, fat digestion, and Hippo signaling critical for metamorphosis, detoxification, pesticide resistance, and pathogen defense. Specific examples include mRNAs for cuticle proteins (e.g., cuticle protein 65), mucin 5AC, ABCG5/ABCG8, and immune-related genes like peptidoglycan recognition proteins (PGRPs) and thioester-containing proteins (TEPs), which enable recognition of bacteria and activation of immune cascades. RNAi knockdown studies have targeted reproductive genes such as ptch1, ap-1, and larp6, demonstrating potential for gene silencing to disrupt mite reproduction and infestation. No specific drugs interact with these mRNAs in therapeutic contexts, but they represent promising RNAi-based targets for mite control to protect bee colonies from Varroa-induced damage and disease transmission.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Varroa destructor essential gene mRNA.